{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T08:31:23Z","timestamp":1704702683328},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Voice"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.jvoice.2010.11.001","type":"journal-article","created":{"date-parts":[[2011,5,10]],"date-time":"2011-05-10T02:53:32Z","timestamp":1304996012000},"page":"e57-e62","source":"Crossref","is-referenced-by-count":7,"title":["Voice-Related Quality of Life in Adults With Neurofibromatosis Type 1"],"prefix":"10.1016","volume":"26","author":[{"given":"Marjan","family":"Cosyns","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geert","family":"Mortier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Van Borsel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvoice.2010.11.001_bib1","series-title":"Neurofibromatosis. A Handbook for Patients, Families, and Health Care Professionals","author":"Korf","year":"2005"},{"key":"10.1016\/j.jvoice.2010.11.001_bib2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ajmg.a.33139","article-title":"Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service","volume":"152A","author":"Evans","year":"2010","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jvoice.2010.11.001_bib3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/archneur.1988.00520290115023","article-title":"Neurofibromatosis. Conference statement","volume":"45","author":"National Institutes of Health Consensus Development Conference","year":"1988","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jvoice.2010.11.001_bib4","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S1474-4422(07)70075-3","article-title":"Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective","volume":"6","author":"Ferner","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jvoice.2010.11.001_bib5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1440-1754.2007.01003.x","article-title":"Retrospective analysis of patients attending a neurofibromatosis type 1 clinic","volume":"43","author":"Noble","year":"2007","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.jvoice.2010.11.001_bib6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1177\/088307389300800421","article-title":"Neurofibromatosis type 1: review of the first 200 patients in an Australian clinic","volume":"8","author":"North","year":"1993","journal-title":"J Child Neurol"},{"key":"10.1016\/j.jvoice.2010.11.001_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/1096-8628(200022)97:2<119::AID-AJMG3>3.0.CO;2-3","article-title":"Neurofibromatosis type 1","volume":"97","author":"North","year":"2000","journal-title":"Am J Med Genet (Semin Med Genet)"},{"key":"10.1016\/j.jvoice.2010.11.001_bib8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0092-8674(90)90253-B","article-title":"A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations","volume":"62","author":"Cawthon","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.jvoice.2010.11.001_bib9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0092-8674(90)90252-A","article-title":"Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus","volume":"62","author":"Viskochil","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.jvoice.2010.11.001_bib10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1126\/science.2134734","article-title":"Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients","volume":"249","author":"Wallace","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.jvoice.2010.11.001_bib11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/WCO.0b013e3280895da8","article-title":"Recent developments in neurofibromatosis type 1","volume":"20","author":"Lee","year":"2007","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.jvoice.2010.11.001_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2008.12.051","article-title":"Neurofibromatosis type 1","volume":"61","author":"Boyd","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jvoice.2010.11.001_bib13","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/hmg\/4.6.975","article-title":"Distribution of 13 truncating mutations in the neurofibromatosis 1 gene","volume":"4","author":"Heim","year":"1995","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jvoice.2010.11.001_bib14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0896-6273(92)90270-N","article-title":"The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes","volume":"8","author":"Daston","year":"1992","journal-title":"Neuron"},{"key":"10.1016\/j.jvoice.2010.11.001_bib15","series-title":"Neurofibromatosis. Phenotype, Natural History, and Pathogenesis","author":"Riccardi","year":"1992"},{"key":"10.1016\/j.jvoice.2010.11.001_bib16","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3109\/13682820903312311","article-title":"Speech disorders in neurofibromatosis type 1: a sample survey","volume":"45","author":"Cosyns","year":"2010","journal-title":"Int J Lang Commun Disord"},{"key":"10.1016\/j.jvoice.2010.11.001_bib17","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJM198112313052704","article-title":"Von Recklinghausen neurofibromatosis","volume":"305","author":"Riccardi","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvoice.2010.11.001_bib18","series-title":"Neurofibromatosis. A Handbook for Patients, Families, and Health Care Professionals","first-page":"83","article-title":"Communication Disorders in Children with NF1","author":"Solot","year":"1998"},{"key":"10.1016\/j.jvoice.2010.11.001_bib19","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/ajmg.a.33235","article-title":"Speech-language characteristics of children with neurofibromatosis type 1","volume":"152A","author":"Thompson","year":"2010","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jvoice.2010.11.001_bib20","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1288\/00005537-198607000-00005","article-title":"Head and neck manifestations of neurofibromatosis","volume":"96","author":"White","year":"1986","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2010.11.001_bib21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ajmg.a.33178","article-title":"Speech characteristics in neurofibromatosis type 1","volume":"152A","author":"Alivuotila","year":"2010","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jvoice.2010.11.001_bib22","article-title":"Voice characteristics in adults with neurofibromatosis type 1","author":"Cosyns","year":"2010","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2010.11.001_bib23","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1044\/1058-0360.0603.66","article-title":"The Voice Handicap Index (VHI): development and validation","volume":"6","author":"Jacobson","year":"1997","journal-title":"Am J Speech Lang Pathol"},{"key":"10.1016\/j.jvoice.2010.11.001_bib24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000187594","article-title":"Health-related quality of life in patients with neurofibromatosis type 1","volume":"218","author":"Kodra","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.jvoice.2010.11.001_bib25","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/ajmg.a.31422","article-title":"Impact of neurofibromatosis 1 on quality of life: a cross-sectional study of 176 American cases","volume":"140A","author":"Page","year":"2006","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jvoice.2010.11.001_bib26","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1001\/archderm.137.11.1421","article-title":"Quality-of-life impairment in neurofibromatosis type 1: a cross-sectional study of 128 cases","volume":"137","author":"Wolkenstein","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jvoice.2010.11.001_bib27","first-page":"29","article-title":"The Voice Handicap Index. An instrument to quantify the psychosocial consequences of voice disorders","volume":"13","author":"De Bodt","year":"2000","journal-title":"Logopedie"},{"key":"10.1016\/j.jvoice.2010.11.001_bib28","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000127836","article-title":"Validation of the Voice Handicap Index by assessing equivalence of European translations","volume":"60","author":"Verdonck-de Leeuw","year":"2008","journal-title":"Folia Phoniatr Logop"},{"key":"10.1016\/j.jvoice.2010.11.001_bib29","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00405-007-0313-1","article-title":"Voice in early glottic cancer compared to benign voice pathology","volume":"264","author":"Van Gogh","year":"2007","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jvoice.2010.11.001_bib30","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1044\/jslhr.4303.796","article-title":"The Dysphonia Severity Index: an objective measure of vocal quality based on a multiparameter approach","volume":"43","author":"Wuyts","year":"2000","journal-title":"J Speech Lang Hear Res"},{"key":"10.1016\/j.jvoice.2010.11.001_bib31","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1159\/000265703","article-title":"Recommendation by the Union of European Phoniatricians (UEP): standardizing voice area measurement\/phonetography","volume":"35","author":"Schutte","year":"1983","journal-title":"Folia Phoniatr Logop"},{"key":"10.1016\/j.jvoice.2010.11.001_bib32","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jvoice.2007.08.007","article-title":"A retrospective study concerning the psychosocial impact of voice disorders: Voice Handicap Index change in patients with benign voice disorders after treatment (measured with the Dutch version of the VHI)","volume":"23","author":"Bouwers","year":"2009","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2010.11.001_bib33","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.clineuro.2007.04.003","article-title":"The effect of levodopa on respiration and word intelligibility in people with advanced Parkinson\u2019s disease","volume":"109","author":"De Letter","year":"2007","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.jvoice.2010.11.001_bib34","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0892-1997(97)80010-0","article-title":"Acoustic voice analysis in patients with Parkinson\u2019s disease treated with dopaminergic drugs","volume":"11","author":"Gamboa","year":"2007","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2010.11.001_bib35","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3109\/17549507.2010.497560","article-title":"Self-perception of speech changes in patients with Parkinson\u2019s disease following deep brain stimulation of the subthalamic nucleus","volume":"12","author":"Frost","year":"2010","journal-title":"Int J Speech Lang Pathol"},{"key":"10.1016\/j.jvoice.2010.11.001_bib36","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/1098-2779(2000)6:2<117::AID-MRDD5>3.0.CO;2-X","article-title":"Behavioral phenotype of neurofibromatosis type 1","volume":"6","author":"Kayl","year":"2000","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"10.1016\/j.jvoice.2010.11.001_bib37","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0755-4982(06)74570-5","article-title":"Neurofibromatosis type 1. Psychiatric disorders and quality of life impairment","volume":"35","author":"Belzeaux","year":"2006","journal-title":"Presse Med"},{"key":"10.1016\/j.jvoice.2010.11.001_bib38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0022-3956(98)00052-1","article-title":"A psychiatric follow-up of adult patients with neurofibromatosis type 1","volume":"33","author":"Z\u00f6ller","year":"1999","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.jvoice.2010.11.001_bib39","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.otohns.2009.08.021","article-title":"Correlation between the Voice Handicap Index and voice measurements in four groups of patients with dysphonia","volume":"141","author":"Schindler","year":"2009","journal-title":"Otolaryngol Head Neck Surg"}],"container-title":["Journal of Voice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892199710002183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892199710002183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,2]],"date-time":"2018-12-02T17:21:40Z","timestamp":1543771300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0892199710002183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0892199710002183"],"URL":"https:\/\/doi.org\/10.1016\/j.jvoice.2010.11.001","relation":{},"ISSN":["0892-1997"],"issn-type":[{"value":"0892-1997","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}